Tim Wakefield

2012 Top 111 Free Agents: Best of the rest

7 Comments

Starting Monday, I’ll be spending the week counting down next winter’s top 111 free agents. First, though, here are some notable names failing to make the cut.

(All ages as of April 1, 2012)

Vicente Padilla (33 – Dodgers): No. 112 on the list. Pitching out of the pen for the first time since 2001, Padilla was briefly the Dodgers’ closer this year and picked up three saves and five holds in nine appearances. Unfortunately, his season is already over due to neck surgery.

Tim Wakefield (45 – Red Sox): If he decides he wants to continue his career, then he’ll be in the top 111 come November. Filling in for Daisuke Matsuzaka, Wakefield has gotten the chance recently to show that he’s still a perfectly viable bottom-of-the-rotation guy, even at age 44. He’s 3-2 with a 4.39 ERA.

Chris Young (32 – Mets): Had a 1.88 ERA in four starts before his latest shoulder injury knocked him out for the season. He’ll be signing another incentive-laden deal this winter.

Bill Hall (32 – Giants): The Astros gave him $3 million to play second base, but he flopped, hitting .224/.272/.340 in 147 at-bats. Now he’s with the Giants trying to rebuild his value.

Mike Cameron (39 – Red Sox): Boston hoped a healthy Cameron would be one of the game’s best fourth outfielders, but he’s hitting just .157 in 83 at-bats. He could opt for retirement after the season.

Mike Gonzalez (33 – Orioles): Gonzalez fanned 90 batters out of the pen for the Braves in 2009, causing the Orioles to sign him as a closer. In the year-plus since, he’s recorded just one save and amassed a 5.29 ERA in 47 2/3 innings.

Brandon Webb (32 – Rangers): After missing more than two years due to shoulder problems, Webb has progressed to the point at which he’s now making rehab starts for the Rangers’ Double-A club. If he’s able to contribute in the second half, he’ll shoot up the list quickly.

Eric Hinske (34 – Braves): Hinske is slumping in an extended role of late, but he’s a rock solid bench player. He’s hit 19 homers in 430 at-bats for the Braves the last two years.

Jerry Hairston Jr. (35 – Nationals): A useful spare part who has received too much playing time the last two years, Hairston can start at any of six positions without hurting a team. He’s hitting .249/.321/.350 in 177 at-bats for the Nationals this season.

Casey Kotchman (29 – Rays): Kotchman has quietly hit .339/.400/.468 in 171 at-bats since getting a chance to overtake Dan Johnson as the Rays’ first baseman.

Joel Zumaya (27 – Tigers): Zumaya had a 2.58 ERA in 38 1/3 innings before suffering a broken elbow on the mound last year. He is questionable to return this season after a follow-up surgery in May. If he misses the entire season, then he’ll probably have to settle for a minor league deal this winter.

Omar Vizquel (44 – White Sox): Still doing a nice job as a utilityman for the White Sox, Vizquel is hitting .279/.312/.360 in 86 at-bats this season. Maybe this will finally be it for him, but he hasn’t given any indication that he’s done.

Jack Wilson (34 – Mariners): Injuries have robbed Wilson of some of his defensive abilities, and it’s not like he can make up for it with his bat. Now buried on the Seattle bench by the Dustin Ackley callup, he badly needs a trade.

Jack Cust (33 – Mariners): Cust doesn’t seem long for Seattle with his playing time starting to go to Mike Carp. He’s still getting on base, but he’s gone from hitting 33 homers in 2008 to just two in 182 at-bats so far this season.

Yuniesky Betancourt (30 – Brewers)*: The Brewers won’t be picking up Betancourt’s $6 million option, and it’s possible that no one will want him as a starting shortstop next year. He’s hitting just .227/.251/.330 at the moment.

Carlos Guillen (36 – Tigers): Guillen, who has yet to play this season, is now hoping to return from knee surgery after the All-Star break. With his four-year, $48 million contract coming to an end, he could possibly have a nice run as a role player in the right situation. He just needs to stay healthy.

Dee Gordon’s suspension is likely to lead to a call for harsher PED penalties

Miami Marlins' Dee Gordon celebrates after hitting a double against the Detroit Tigers in the ninth inning of a baseball game Tuesday, April 5, 2016, in Miami. Derek Dietrich scored on the double. The Tigers won 8-7. (AP Photo/Alan Diaz)
Associated Press
19 Comments

Objectively speaking there is no difference between Dee Gordon’s suspension for PEDs and anyone else’s. Abraham Almonte, for example. Or Cameron Maybin. Or David Rollins. All were guys who got their 80 games, served their time, came back and whose cases didn’t raise too much of a fuss. But Gordon’s suspension will almost certainly be talked about longer and more loudly and will likely lead to calls for harsher penalties and changes to the PED suspension rules.

Part of it is simply fame. He’s a pretty big name as far as these things go. The biggest since the Biogenesis guys a couple of years ago. He won the batting title last year. He’s the son of a famous major leaguer. There is a direct correlation between the volume and intensity of the narratives applied to one’s story and the fame of the subject of the story. For that reason alone Gordon’s story will last longer and loom larger.

Another reason — a bigger reason, I think — is timing. Gordon was seen by many to have had a breakout season in 2015 and, when it was over, he was rewarded for it with a nice five-year $50 million deal. The narrative will arise by, oh, 9AM today, that the suspension was “worth it” for Gordon and that he cashed in because of it, rendering his suspension a mere slap on the wrist. This is especially true given that his deal is severely backloaded. He’ll lose less than $2 million in salary in 2016 while collecting the other $48 million-plus. Totally worth it!

I understand why people will say that, but such a stance has some serious flaws. Among them:

  • It assumes that we or anyone else knows when Gordon began to take PEDs;
  • It assumes that we or anyone else knows how, in fact, Gordon’s performance was actually enhanced;
  • It forgets that lots and lots of people were talking about how Gordon’s “breakout season” was actually 2014, not 2015, rendering that whole “he juiced and then got his money” argument fairly problematic.

Those points will likely be ignored as arguments in favor of harsher penalties grow louder. Ken Rosenthal reminds us this morning that some have called for some form of contract voiding or clawing back of more money than just the salary earned while on suspension. Those calls too will likely grow louder. There will also be calls for changes in the appeal process. Like this one, which came moments after Gordon’s suspension was announced:

When you have an actual union member angrily call for the repeal of a collectively-bargained protection in punishment situations, you’re sort of through the looking glass. Or past a tipping point. Or something. You’re certainly in a world where the usual dynamics between employer and employee are not operative and, as a result, changes are inevitable. As we noted recently, players today are perhaps more adamantly anti-PED than the owners and the league are. They’re competitors reacting to cheating by their competition. The fuel for stronger penalties is likely to come more from them than anyone.

The union and the league will be negotiating a new Collective Bargaining Agreement this year. Performance enhancing drugs and their penalties will be a part of that. Expect harsher penalties and possibly different sorts of rules altogether. Expect Dee Gordon to be the poster child for these changes, even if his case is no different in form than that of Abraham Almonte, Cameron Maybin, or David Rollins. Expect emotion, rather than logic, to lead the coming debate.

And That Happened: Thursdays scores and highlights

Atlanta Braves relief pitcher Arodys Vizcaino, right, is congratulated by catcher Tyler Flowers after earning a save during a baseball game against the Boston Red Sox at Fenway Park in Boston, Thursday, April 28, 2016. The Braves defeated the Red Sox 5-3. (AP Photo/Charles Krupa)
5 Comments

Gonna mail this one in this morning. Partially because of the light slate of games yesterday, partially because of a late night for me but mostly because of the Dee Gordon news which has me thinking of a lot of other things I want to write about this AM.

It’s worth noting that the Braves won a game. It comes just ahead of a series at Wrigley against the Cubs, so the winning streak will likely last a single day, but the 2016 Braves have to take what they can get.

The Marlins had a notable night outside the Gordon news too, finishing off a sweep of the Dodgers, which had to make Don Mattingly happy. For what it’s worth, Gordon singled in a run and then came around to score in the seventh. His RBI tied it and the run he scored ended up being the one necessary for the Marlins’ margin of victory. That means nothing, but you know some jackwagons are gonna make a big deal out of that and I figured I’d get ahead of the jackwagons and note that, yes, Gordon and the Marlins knew what was coming before it was announced because that’s how the appeals process works, but no, it makes no difference, because that’s how the appeals process works.

Anyway: Here are the rest of the scores:

Tigers 7, Athletics 3
Cubs 7, Brewers 2
Phillies 3, Nationals 0
Orioles 10, White Sox 2
Braves 5, Red Sox 3
Diamondbacks 3, Cardinals 0
Marlins 5, Dodgers 3
Pirates vs. Rockies — POSTPONED
: In the early morning rain with a dollar in my hand. And an aching in my heart, and my pockets full of sand. I’m a long way from home, and I miss my loved one so. In the early morning rain with no place to go.

Marlins 2B Dee Gordon suspended 80 games for PEDs

deegordon
Getty Images
38 Comments

LOS ANGELES — Dee Gordon has been suspended 80 games by Major League Baseball after the Miami Marlins second baseman tested positive for a performance-enhancing drug.

Gordon tested positive for exogenous Testosterone and Clostebol, MLB said in a release after the Marlins’ 5-3 victory over the Los Angeles Dodgers on Thursday night.

The fleet-footed Gordon won the National League batting title by hitting .333 last season and signed a $50 million, 5-year deal with Miami in January. He’s made two All-Star teams in his six seasons and won the Gold Glove and Silver Slugger awards at second base last year.

Gordon, the son of former major league pitcher Tom Gordon, had a key hit in Miami’s win over the Dodgers on Thursday. He’s batting .266 with six stolen bases this season.

Dee Gordon is a very important part of our team, and we all love him and support him,” Marlins president David Samson said. “That said, I don’t like or condone what he did. He is an important member of this organization and will be for many years to come. It’s a huge, huge disappointment to the kids, to our fans, to his teammates and to everyone in our organization every single day.

“He will be back 80 games from now, and he will be welcomed back to this organization. But in the interim period, we expect him, and we are positive that he will do everything that’s necessary to make it up to his fans, to his teammates and to this organization.”

Devon Travis will start taking at-bats in extended spring training

Toronto Blue Jays second baseman Devon Travis hits a RBI double to center field against the Tampa Bay Rays during third inning of a baseball game, Wednesday, April 15, 2015 in Toronto. (Nathan Denette/The Canadian Press via AP)  MANDATORY CREDIT
Nathan Denette/The Canadian Press via AP
4 Comments

Blue Jays second baseman Devon Travis underwent left shoulder surgery last September. MLB.com’s Gregor Chisholm caught up with Jays head athletic trainer George Poulis for updates on several injured players, including Travis. Here’s what Poulis had to say about Travis:

“He’s going to get some live at-bats with the extended team down in Florida on Friday. Big step for him, he’s very excited, he’s doing great, and we’re very optimistic, but no timeline right now on his return. We’re just going day by day, step by step.

“When you have something like that, it continues to heal even when you’re playing. We’re just trying to acclimate him and condition him to withstand all of the stress that he’s going to put on his shoulder … He won’t play in the field right now. We’ll mix that in, as well, but right now he’s just going to get some at-bats.”

The key phrase, of course, is “no timetable”. The second baseman’s rehab has gone slower than expected. Getting into some extended spring training games, though, signals progress.

Travis, 25, broke out last season, hitting .304/.361/.498 with eight home runs and 35 RBI in 239 plate appearances last season. The Jays have had Ryan Goins and Darwin Barney handle second base duties this year, but their aggregate .560 OPS is the worst mark in the American League.